VitaSpring Biomedical Co. Ltd.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Apr 2017 | $-2.3K | $-2.3K | — | — |
| Jul 2017 | $-1.6K | $-1.6K | — | — |
| Oct 2017 | $-554 | $-554 | — | — |
| Jan 2018 | $4.8K | $4.8K | — | — |
| Apr 2018 | $-3.0K | $-3.0K | — | — |
| Jul 2018 | $-14.6K | $-14.6K | — | — |
| Oct 2018 | $-19.8K | $-19.8K | — | — |
| Jan 2019 | $3.1K | $3.1K | — | — |
| Apr 2019 | $1.5K | $1.5K | — | — |
| Jul 2019 | $-1.2K | $-1.2K | — | — |
| Oct 2019 | $-284 | $-284 | — | — |
| Jan 2020 | $-134 | $-134 | — | — |
| Apr 2020 | $893 | $893 | — | — |
| Jul 2020 | $-165 | $-165 | — | — |
| Oct 2020 | $0 | $0 | — | — |
| Jan 2021 | $-42.9K | $-42.9K | — | — |
| Apr 2021 | $358.9K | $358.9K | — | $35.1K |
| Jul 2021 | $-977.3K | $-977.3K | — | $44.0K |
| Oct 2021 | $376.8K | $376.8K | — | $44.0K |
| Jan 2022 | $-28.0K | $-28.0K | — | $44.0K |
| Apr 2022 | $-28.1K | $-28.1K | — | $36.5K |
| Jul 2022 | $-57.6K | $-57.6K | — | $73.0K |
| Oct 2022 | $2.5K | $2.5K | — | $36.5K |
| Jan 2023 | $5.6K | $5.6K | — | $44.3K |
| Apr 2023 | $-27.9K | $-27.9K | — | $41.2K |
| Jul 2023 | $188 | $188 | — | $41.2K |
| Oct 2023 | $-4.5K | $-4.5K | — | $41.2K |
| Jan 2024 | $-2.6K | $-2.6K | — | $41.2K |
| Apr 2024 | $-4.0K | $-4.0K | — | $41.2K |
| Jul 2024 | $-2.4K | $-2.4K | — | $41.2K |
| Oct 2024 | $-6.4K | $-6.4K | — | $27.5K |
| Jan 2025 | $-1.8K | $-1.8K | — | $0 |
| Apr 2025 | $-787 | $-787 | — | $0 |
| Jul 2025 | $-1.2K | $-1.2K | — | $0 |
| Oct 2025 | $-839 | $-839 | — | $0 |
| Jan 2026 | $124 | $124 | — | $0 |
| Apr 2026 | $6.1K | $6.1K | — | — |
| Jul 2026 | $5.2K | $5.2K | — | — |